1. Home
  2. LSPD vs NVAX Comparison

LSPD vs NVAX Comparison

Compare LSPD & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lightspeed Commerce Inc. Subordinate Voting Shares

LSPD

Lightspeed Commerce Inc. Subordinate Voting Shares

HOLD

Current Price

$12.23

Market Cap

1.6B

Sector

N/A

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.64

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSPD
NVAX
Founded
2005
1987
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.1B
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
LSPD
NVAX
Price
$12.23
$6.64
Analyst Decision
Buy
Hold
Analyst Count
15
9
Target Price
$13.63
$10.78
AVG Volume (30 Days)
451.8K
3.3M
Earning Date
02-05-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.07
Revenue
$1,157,458,000.00
$1,064,651,000.00
Revenue This Year
$15.25
$58.91
Revenue Next Year
$11.85
N/A
P/E Ratio
N/A
$3.15
Revenue Growth
14.24
20.27
52 Week Low
$7.34
$5.01
52 Week High
$16.74
$11.55

Technical Indicators

Market Signals
Indicator
LSPD
NVAX
Relative Strength Index (RSI) 56.42 43.18
Support Level $11.54 $6.36
Resistance Level $12.69 $6.76
Average True Range (ATR) 0.45 0.21
MACD 0.08 0.04
Stochastic Oscillator 72.81 46.67

Price Performance

Historical Comparison
LSPD
NVAX

About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares

Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, United Kingdom, Australia, and other countries. It derives a majority of its revenue from the United States.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: